Gene therapy for arthritis
The ability of immune cells to home to peripheral lymphoid organs or target tissues is critical to autoimmune pathogenesis, but it also makes these cells a promising vehicle for delivering therapeutic agents to the relevant tissues. Two reports in this issue apply this principle to suppress collagen-induced arthritis (CIA), a mouse model of rheumatoid arthritis. Contact: John Ashkenas scied@the-jci.org 416-946-7593 Journal of Clinical Investigation
Message posted by: Wouter Kalle
|